No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 23.800
- +0.760+3.30%
Close Dec 20 16:00 ET
- 23.800
- 0.0000.00%
Post 16:20 ET
704.41MMarket Cap-10.42P/E (TTM)
24.215High22.350Low389.93KVolume22.790Open23.040Pre Close9.20MTurnover3.13%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High2.08P/B296.82MFloat Cap10.02052wk Low--Dividend TTM12.47MShs Float336.000Historical High--Div YieldTTM8.10%Amplitude5.136Historical Low23.602Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Forecasting The Future: 5 Analyst Projections For Dianthus Therapeutics
TD Cowen Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating
TD Cowen Initiates Coverage on Dianthus Therapeutics With Buy Rating
Stifel Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $52
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Oppenheimer Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $52
Heat List
US
Overall
Symbol
Price
% Chg
No Data